nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupivacaine—PTGER1—Bimatoprost—glaucoma	0.507	0.678	CbGbCtD
Bupivacaine—CYP2D6—Carteolol—glaucoma	0.0319	0.0427	CbGbCtD
Bupivacaine—CYP1A2—Betaxolol—glaucoma	0.0262	0.035	CbGbCtD
Bupivacaine—CYP2D6—Betaxolol—glaucoma	0.0216	0.0288	CbGbCtD
Bupivacaine—CYP2C19—Methazolamide—glaucoma	0.0215	0.0287	CbGbCtD
Bupivacaine—CYP2C19—Timolol—glaucoma	0.0183	0.0244	CbGbCtD
Bupivacaine—CYP2D6—Methazolamide—glaucoma	0.0163	0.0218	CbGbCtD
Bupivacaine—CYP3A4—Pilocarpine—glaucoma	0.0154	0.0206	CbGbCtD
Bupivacaine—CYP1A2—Clonidine—glaucoma	0.0143	0.0192	CbGbCtD
Bupivacaine—CYP2D6—Timolol—glaucoma	0.0139	0.0186	CbGbCtD
Bupivacaine—CYP3A4—Brinzolamide—glaucoma	0.0121	0.0161	CbGbCtD
Bupivacaine—CYP2D6—Clonidine—glaucoma	0.0118	0.0158	CbGbCtD
Bupivacaine—CYP3A4—Dorzolamide—glaucoma	0.0117	0.0156	CbGbCtD
Bupivacaine—CYP3A4—Methazolamide—glaucoma	0.0104	0.0139	CbGbCtD
Bupivacaine—CYP3A4—Acetazolamide—glaucoma	0.00831	0.0111	CbGbCtD
Bupivacaine—CYP3A4—Clonidine—glaucoma	0.00751	0.01	CbGbCtD
Bupivacaine—PTGER1—Prostanoid ligand receptors—PTGFR—glaucoma	0.00656	0.143	CbGpPWpGaD
Bupivacaine—PTGER1—Eicosanoid ligand-binding receptors—PTGFR—glaucoma	0.00436	0.0947	CbGpPWpGaD
Bupivacaine—PTGER1—Prostaglandin Synthesis and Regulation—ANXA3—glaucoma	0.00367	0.0797	CbGpPWpGaD
Bupivacaine—PTGER1—Small Ligand GPCRs—PTGFR—glaucoma	0.00361	0.0784	CbGpPWpGaD
Bupivacaine—PTGER1—Prostaglandin Synthesis and Regulation—PTGFR—glaucoma	0.00251	0.0544	CbGpPWpGaD
Bupivacaine—PTGER1—Prostaglandin Synthesis and Regulation—EDN1—glaucoma	0.000833	0.0181	CbGpPWpGaD
Bupivacaine—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—glaucoma	0.000815	0.0177	CbGpPWpGaD
Bupivacaine—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000718	0.0156	CbGpPWpGaD
Bupivacaine—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000653	0.0142	CbGpPWpGaD
Bupivacaine—PTGER1—G alpha (q) signalling events—OPN4—glaucoma	0.000644	0.014	CbGpPWpGaD
Bupivacaine—PTGER1—G alpha (q) signalling events—PTGFR—glaucoma	0.00058	0.0126	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.000576	0.0125	CbGpPWpGaD
Bupivacaine—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.000559	0.0121	CbGpPWpGaD
Bupivacaine—PTGER1—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.000544	0.0118	CbGpPWpGaD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.000518	0.0113	CbGpPWpGaD
Bupivacaine—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.000509	0.0111	CbGpPWpGaD
Bupivacaine—CYP1A2—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000498	0.0108	CbGpPWpGaD
Bupivacaine—PTGER1—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.000498	0.0108	CbGpPWpGaD
Bupivacaine—PTGER1—Prostaglandin Synthesis and Regulation—PTGS2—glaucoma	0.000464	0.0101	CbGpPWpGaD
Bupivacaine—PTGER1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000448	0.00973	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000426	0.00926	CbGpPWpGaD
Bupivacaine—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.000393	0.00853	CbGpPWpGaD
Bupivacaine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.000384	0.00834	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000384	0.00833	CbGpPWpGaD
Bupivacaine—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.000379	0.00824	CbGpPWpGaD
Bupivacaine—CYP2C19—Tamoxifen metabolism—CYP1B1—glaucoma	0.000332	0.0072	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—OPN4—glaucoma	0.000325	0.00705	CbGpPWpGaD
Bupivacaine—CYP2D6—Tamoxifen metabolism—CYP1B1—glaucoma	0.000305	0.00662	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—NCK2—glaucoma	0.000298	0.00648	CbGpPWpGaD
Bupivacaine—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.000292	0.00635	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—PTGFR—glaucoma	0.000292	0.00635	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—NCK2—glaucoma	0.000288	0.00625	CbGpPWpGaD
Bupivacaine—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.000258	0.00561	CbGpPWpGaD
Bupivacaine—CYP2C19—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000256	0.00556	CbGpPWpGaD
Bupivacaine—CYP2D6—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000236	0.00512	CbGpPWpGaD
Bupivacaine—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.000234	0.00507	CbGpPWpGaD
Bupivacaine—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000226	0.0049	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—NCK2—glaucoma	0.000213	0.00462	CbGpPWpGaD
Bupivacaine—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	0.000207	0.0045	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—NCK2—glaucoma	0.000205	0.00446	CbGpPWpGaD
Bupivacaine—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.0002	0.00433	CbGpPWpGaD
Bupivacaine—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.000199	0.00433	CbGpPWpGaD
Bupivacaine—PTGER1—G alpha (q) signalling events—EDN1—glaucoma	0.000193	0.00418	CbGpPWpGaD
Bupivacaine—CYP2D6—Melatonin metabolism and effects—EDN1—glaucoma	0.000191	0.00414	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—OPN4—glaucoma	0.000183	0.00398	CbGpPWpGaD
Bupivacaine—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.00018	0.00392	CbGpPWpGaD
Bupivacaine—Hypersensitivity—Apraclonidine—glaucoma	0.000176	0.000855	CcSEcCtD
Bupivacaine—Nervousness—Clonidine—glaucoma	0.000176	0.000855	CcSEcCtD
Bupivacaine—Paraesthesia—Dorzolamide—glaucoma	0.000176	0.000855	CcSEcCtD
Bupivacaine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000176	0.00382	CbGpPWpGaD
Bupivacaine—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000176	0.000853	CcSEcCtD
Bupivacaine—Pain—Brimonidine—glaucoma	0.000176	0.000852	CcSEcCtD
Bupivacaine—Dyspnoea—Dorzolamide—glaucoma	0.000175	0.000849	CcSEcCtD
Bupivacaine—Insomnia—Brinzolamide—glaucoma	0.000174	0.000846	CcSEcCtD
Bupivacaine—Somnolence—Dorzolamide—glaucoma	0.000174	0.000846	CcSEcCtD
Bupivacaine—Muscle spasms—Clonidine—glaucoma	0.000174	0.000846	CcSEcCtD
Bupivacaine—Dyspnoea—Travoprost—glaucoma	0.000174	0.000845	CcSEcCtD
Bupivacaine—Hypotension—Pilocarpine—glaucoma	0.000173	0.000841	CcSEcCtD
Bupivacaine—Paraesthesia—Brinzolamide—glaucoma	0.000173	0.00084	CcSEcCtD
Bupivacaine—Dyspepsia—Dorzolamide—glaucoma	0.000173	0.000838	CcSEcCtD
Bupivacaine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000172	0.00374	CbGpPWpGaD
Bupivacaine—Dyspnoea—Brinzolamide—glaucoma	0.000172	0.000834	CcSEcCtD
Bupivacaine—Dyspepsia—Travoprost—glaucoma	0.000172	0.000834	CcSEcCtD
Bupivacaine—Asthenia—Apraclonidine—glaucoma	0.000172	0.000833	CcSEcCtD
Bupivacaine—Somnolence—Brinzolamide—glaucoma	0.000171	0.000832	CcSEcCtD
Bupivacaine—Vision blurred—Clonidine—glaucoma	0.000171	0.000829	CcSEcCtD
Bupivacaine—Decreased appetite—Dorzolamide—glaucoma	0.00017	0.000828	CcSEcCtD
Bupivacaine—Urticaria—Acetazolamide—glaucoma	0.00017	0.000825	CcSEcCtD
Bupivacaine—Tremor—Clonidine—glaucoma	0.00017	0.000825	CcSEcCtD
Bupivacaine—Dyspepsia—Brinzolamide—glaucoma	0.00017	0.000824	CcSEcCtD
Bupivacaine—Pruritus—Apraclonidine—glaucoma	0.000169	0.000821	CcSEcCtD
Bupivacaine—Body temperature increased—Acetazolamide—glaucoma	0.000169	0.000821	CcSEcCtD
Bupivacaine—Tinnitus—Betaxolol—glaucoma	0.000169	0.000821	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000169	0.00082	CcSEcCtD
Bupivacaine—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	0.000169	0.00366	CbGpPWpGaD
Bupivacaine—Gastrointestinal disorder—Travoprost—glaucoma	0.000169	0.000818	CcSEcCtD
Bupivacaine—Flushing—Betaxolol—glaucoma	0.000168	0.000817	CcSEcCtD
Bupivacaine—Cardiac disorder—Betaxolol—glaucoma	0.000168	0.000817	CcSEcCtD
Bupivacaine—Pain—Dorzolamide—glaucoma	0.000168	0.000814	CcSEcCtD
Bupivacaine—Insomnia—Pilocarpine—glaucoma	0.000168	0.000814	CcSEcCtD
Bupivacaine—Decreased appetite—Brinzolamide—glaucoma	0.000168	0.000814	CcSEcCtD
Bupivacaine—Constipation—Travoprost—glaucoma	0.000167	0.000811	CcSEcCtD
Bupivacaine—Pain—Travoprost—glaucoma	0.000167	0.000811	CcSEcCtD
Bupivacaine—PTGER1—Signaling by GPCR—OPN4—glaucoma	0.000167	0.00362	CbGpPWpGaD
Bupivacaine—Agitation—Clonidine—glaucoma	0.000167	0.000809	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000166	0.000808	CcSEcCtD
Bupivacaine—Paraesthesia—Pilocarpine—glaucoma	0.000166	0.000808	CcSEcCtD
Bupivacaine—Asthenia—Bimatoprost—glaucoma	0.000166	0.000808	CcSEcCtD
Bupivacaine—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000166	0.0036	CbGpPWpGaD
Bupivacaine—Angioedema—Clonidine—glaucoma	0.000166	0.000804	CcSEcCtD
Bupivacaine—PTGER1—GPCR downstream signaling—PTGFR—glaucoma	0.000165	0.00359	CbGpPWpGaD
Bupivacaine—Dyspnoea—Pilocarpine—glaucoma	0.000165	0.000802	CcSEcCtD
Bupivacaine—Pain—Brinzolamide—glaucoma	0.000165	0.0008	CcSEcCtD
Bupivacaine—Somnolence—Pilocarpine—glaucoma	0.000165	0.0008	CcSEcCtD
Bupivacaine—Pruritus—Bimatoprost—glaucoma	0.000164	0.000796	CcSEcCtD
Bupivacaine—Diarrhoea—Apraclonidine—glaucoma	0.000164	0.000794	CcSEcCtD
Bupivacaine—Dyspepsia—Pilocarpine—glaucoma	0.000163	0.000792	CcSEcCtD
Bupivacaine—Chills—Betaxolol—glaucoma	0.000163	0.00079	CcSEcCtD
Bupivacaine—Syncope—Clonidine—glaucoma	0.000163	0.000789	CcSEcCtD
Bupivacaine—Arrhythmia—Betaxolol—glaucoma	0.000162	0.000786	CcSEcCtD
Bupivacaine—Feeling abnormal—Dorzolamide—glaucoma	0.000162	0.000784	CcSEcCtD
Bupivacaine—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000161	0.00351	CbGpPWpGaD
Bupivacaine—Decreased appetite—Pilocarpine—glaucoma	0.000161	0.000782	CcSEcCtD
Bupivacaine—Feeling abnormal—Travoprost—glaucoma	0.000161	0.000781	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Dorzolamide—glaucoma	0.00016	0.000778	CcSEcCtD
Bupivacaine—Palpitations—Clonidine—glaucoma	0.00016	0.000778	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Pilocarpine—glaucoma	0.00016	0.000777	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Travoprost—glaucoma	0.00016	0.000775	CcSEcCtD
Bupivacaine—Loss of consciousness—Clonidine—glaucoma	0.000159	0.000774	CcSEcCtD
Bupivacaine—Feeling abnormal—Brinzolamide—glaucoma	0.000159	0.000771	CcSEcCtD
Bupivacaine—Mental disorder—Betaxolol—glaucoma	0.000159	0.000771	CcSEcCtD
Bupivacaine—Pain—Pilocarpine—glaucoma	0.000158	0.000769	CcSEcCtD
Bupivacaine—Constipation—Pilocarpine—glaucoma	0.000158	0.000769	CcSEcCtD
Bupivacaine—Cough—Clonidine—glaucoma	0.000158	0.000768	CcSEcCtD
Bupivacaine—Sweating—Timolol—glaucoma	0.000158	0.000768	CcSEcCtD
Bupivacaine—Dizziness—Apraclonidine—glaucoma	0.000158	0.000768	CcSEcCtD
Bupivacaine—Malnutrition—Betaxolol—glaucoma	0.000158	0.000766	CcSEcCtD
Bupivacaine—Erythema—Betaxolol—glaucoma	0.000158	0.000766	CcSEcCtD
Bupivacaine—Urticaria—Dorzolamide—glaucoma	0.000156	0.000756	CcSEcCtD
Bupivacaine—CYP2D6—Melatonin metabolism and effects—APOE—glaucoma	0.000155	0.00337	CbGpPWpGaD
Bupivacaine—Body temperature increased—Dorzolamide—glaucoma	0.000155	0.000753	CcSEcCtD
Bupivacaine—Abdominal pain—Dorzolamide—glaucoma	0.000155	0.000753	CcSEcCtD
Bupivacaine—Tension—Betaxolol—glaucoma	0.000155	0.000752	CcSEcCtD
Bupivacaine—Arthralgia—Clonidine—glaucoma	0.000154	0.000749	CcSEcCtD
Bupivacaine—Abdominal pain—Travoprost—glaucoma	0.000154	0.000749	CcSEcCtD
Bupivacaine—Anxiety—Clonidine—glaucoma	0.000154	0.000747	CcSEcCtD
Bupivacaine—Asthenia—Acetazolamide—glaucoma	0.000153	0.000745	CcSEcCtD
Bupivacaine—Dizziness—Bimatoprost—glaucoma	0.000153	0.000744	CcSEcCtD
Bupivacaine—Nervousness—Betaxolol—glaucoma	0.000153	0.000744	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.000153	0.000744	CcSEcCtD
Bupivacaine—Urticaria—Brinzolamide—glaucoma	0.000153	0.000743	CcSEcCtD
Bupivacaine—Feeling abnormal—Pilocarpine—glaucoma	0.000153	0.000741	CcSEcCtD
Bupivacaine—Vomiting—Apraclonidine—glaucoma	0.000152	0.000738	CcSEcCtD
Bupivacaine—Muscle spasms—Betaxolol—glaucoma	0.000152	0.000737	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Pilocarpine—glaucoma	0.000151	0.000736	CcSEcCtD
Bupivacaine—Hypersensitivity—Brimonidine—glaucoma	0.000151	0.000734	CcSEcCtD
Bupivacaine—Bradycardia—Timolol—glaucoma	0.000151	0.000732	CcSEcCtD
Bupivacaine—PTGER1—Signaling by GPCR—PTGFR—glaucoma	0.00015	0.00326	CbGpPWpGaD
Bupivacaine—Headache—Apraclonidine—glaucoma	0.00015	0.000727	CcSEcCtD
Bupivacaine—Confusional state—Clonidine—glaucoma	0.000149	0.000724	CcSEcCtD
Bupivacaine—Vision blurred—Betaxolol—glaucoma	0.000149	0.000722	CcSEcCtD
Bupivacaine—Oedema—Clonidine—glaucoma	0.000148	0.000718	CcSEcCtD
Bupivacaine—Tremor—Betaxolol—glaucoma	0.000148	0.000718	CcSEcCtD
Bupivacaine—PTGER1—GPCR ligand binding—SMO—glaucoma	0.000147	0.0032	CbGpPWpGaD
Bupivacaine—Asthenia—Brimonidine—glaucoma	0.000147	0.000715	CcSEcCtD
Bupivacaine—Infection—Clonidine—glaucoma	0.000147	0.000714	CcSEcCtD
Bupivacaine—Abdominal pain—Pilocarpine—glaucoma	0.000146	0.000711	CcSEcCtD
Bupivacaine—Body temperature increased—Pilocarpine—glaucoma	0.000146	0.000711	CcSEcCtD
Bupivacaine—Diarrhoea—Acetazolamide—glaucoma	0.000146	0.000711	CcSEcCtD
Bupivacaine—Oedema peripheral—Timolol—glaucoma	0.000146	0.000708	CcSEcCtD
Bupivacaine—Anaemia—Betaxolol—glaucoma	0.000146	0.000708	CcSEcCtD
Bupivacaine—Shock—Clonidine—glaucoma	0.000146	0.000707	CcSEcCtD
Bupivacaine—Pruritus—Brimonidine—glaucoma	0.000145	0.000705	CcSEcCtD
Bupivacaine—Headache—Bimatoprost—glaucoma	0.000145	0.000705	CcSEcCtD
Bupivacaine—Nervous system disorder—Clonidine—glaucoma	0.000145	0.000704	CcSEcCtD
Bupivacaine—Hypersensitivity—Dorzolamide—glaucoma	0.000144	0.000701	CcSEcCtD
Bupivacaine—Tachycardia—Clonidine—glaucoma	0.000144	0.000701	CcSEcCtD
Bupivacaine—Hypersensitivity—Travoprost—glaucoma	0.000144	0.000698	CcSEcCtD
Bupivacaine—Skin disorder—Clonidine—glaucoma	0.000144	0.000698	CcSEcCtD
Bupivacaine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000143	0.00311	CbGpPWpGaD
Bupivacaine—Hyperhidrosis—Clonidine—glaucoma	0.000143	0.000694	CcSEcCtD
Bupivacaine—Nausea—Apraclonidine—glaucoma	0.000142	0.00069	CcSEcCtD
Bupivacaine—Hypersensitivity—Brinzolamide—glaucoma	0.000142	0.00069	CcSEcCtD
Bupivacaine—PTGER1—Signaling Pathways—LRP12—glaucoma	0.000142	0.00308	CbGpPWpGaD
Bupivacaine—Syncope—Betaxolol—glaucoma	0.000142	0.000687	CcSEcCtD
Bupivacaine—Dizziness—Acetazolamide—glaucoma	0.000141	0.000687	CcSEcCtD
Bupivacaine—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000141	0.00307	CbGpPWpGaD
Bupivacaine—Asthenia—Dorzolamide—glaucoma	0.000141	0.000683	CcSEcCtD
Bupivacaine—Asthenia—Travoprost—glaucoma	0.00014	0.00068	CcSEcCtD
Bupivacaine—Palpitations—Betaxolol—glaucoma	0.000139	0.000677	CcSEcCtD
Bupivacaine—Pruritus—Dorzolamide—glaucoma	0.000139	0.000673	CcSEcCtD
Bupivacaine—Loss of consciousness—Betaxolol—glaucoma	0.000139	0.000673	CcSEcCtD
Bupivacaine—Asthenia—Brinzolamide—glaucoma	0.000138	0.000671	CcSEcCtD
Bupivacaine—Hypotension—Clonidine—glaucoma	0.000138	0.000671	CcSEcCtD
Bupivacaine—Pruritus—Travoprost—glaucoma	0.000138	0.000671	CcSEcCtD
Bupivacaine—Tinnitus—Timolol—glaucoma	0.000138	0.00067	CcSEcCtD
Bupivacaine—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.000138	0.003	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.000138	0.003	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.000138	0.003	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—PAX6—glaucoma	0.000138	0.003	CbGpPWpGaD
Bupivacaine—Cough—Betaxolol—glaucoma	0.000138	0.000669	CcSEcCtD
Bupivacaine—Nausea—Bimatoprost—glaucoma	0.000138	0.000669	CcSEcCtD
Bupivacaine—Cardiac disorder—Timolol—glaucoma	0.000137	0.000667	CcSEcCtD
Bupivacaine—Hypersensitivity—Pilocarpine—glaucoma	0.000136	0.000663	CcSEcCtD
Bupivacaine—Pruritus—Brinzolamide—glaucoma	0.000136	0.000662	CcSEcCtD
Bupivacaine—Vomiting—Acetazolamide—glaucoma	0.000136	0.00066	CcSEcCtD
Bupivacaine—Dizziness—Brimonidine—glaucoma	0.000136	0.000659	CcSEcCtD
Bupivacaine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000136	0.00295	CbGpPWpGaD
Bupivacaine—Musculoskeletal discomfort—Clonidine—glaucoma	0.000135	0.000654	CcSEcCtD
Bupivacaine—Arthralgia—Betaxolol—glaucoma	0.000134	0.000652	CcSEcCtD
Bupivacaine—Diarrhoea—Dorzolamide—glaucoma	0.000134	0.000651	CcSEcCtD
Bupivacaine—Headache—Acetazolamide—glaucoma	0.000134	0.000651	CcSEcCtD
Bupivacaine—Anxiety—Betaxolol—glaucoma	0.000134	0.00065	CcSEcCtD
Bupivacaine—Insomnia—Clonidine—glaucoma	0.000134	0.00065	CcSEcCtD
Bupivacaine—Diarrhoea—Travoprost—glaucoma	0.000134	0.000649	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000133	0.000648	CcSEcCtD
Bupivacaine—SCN10A—Developmental Biology—PAX6—glaucoma	0.000133	0.00289	CbGpPWpGaD
Bupivacaine—Asthenia—Pilocarpine—glaucoma	0.000133	0.000645	CcSEcCtD
Bupivacaine—Paraesthesia—Clonidine—glaucoma	0.000133	0.000645	CcSEcCtD
Bupivacaine—Arrhythmia—Timolol—glaucoma	0.000132	0.000642	CcSEcCtD
Bupivacaine—Dyspnoea—Clonidine—glaucoma	0.000132	0.00064	CcSEcCtD
Bupivacaine—Diarrhoea—Brinzolamide—glaucoma	0.000132	0.00064	CcSEcCtD
Bupivacaine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000132	0.00286	CbGpPWpGaD
Bupivacaine—Somnolence—Clonidine—glaucoma	0.000132	0.000639	CcSEcCtD
Bupivacaine—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000131	0.00285	CbGpPWpGaD
Bupivacaine—Pruritus—Pilocarpine—glaucoma	0.000131	0.000636	CcSEcCtD
Bupivacaine—CYP2D6—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00013	0.00282	CbGpPWpGaD
Bupivacaine—Confusional state—Betaxolol—glaucoma	0.00013	0.000631	CcSEcCtD
Bupivacaine—Mental disorder—Timolol—glaucoma	0.00013	0.00063	CcSEcCtD
Bupivacaine—Dizziness—Dorzolamide—glaucoma	0.00013	0.000629	CcSEcCtD
Bupivacaine—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000129	0.0028	CbGpPWpGaD
Bupivacaine—Dizziness—Travoprost—glaucoma	0.000129	0.000627	CcSEcCtD
Bupivacaine—Malnutrition—Timolol—glaucoma	0.000129	0.000626	CcSEcCtD
Bupivacaine—Erythema—Timolol—glaucoma	0.000129	0.000626	CcSEcCtD
Bupivacaine—Oedema—Betaxolol—glaucoma	0.000129	0.000625	CcSEcCtD
Bupivacaine—Headache—Brimonidine—glaucoma	0.000129	0.000624	CcSEcCtD
Bupivacaine—Decreased appetite—Clonidine—glaucoma	0.000129	0.000624	CcSEcCtD
Bupivacaine—Infection—Betaxolol—glaucoma	0.000128	0.000621	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Clonidine—glaucoma	0.000128	0.00062	CcSEcCtD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000128	0.00277	CbGpPWpGaD
Bupivacaine—Dizziness—Brinzolamide—glaucoma	0.000127	0.000619	CcSEcCtD
Bupivacaine—Nausea—Acetazolamide—glaucoma	0.000127	0.000617	CcSEcCtD
Bupivacaine—Diarrhoea—Pilocarpine—glaucoma	0.000127	0.000615	CcSEcCtD
Bupivacaine—Shock—Betaxolol—glaucoma	0.000127	0.000615	CcSEcCtD
Bupivacaine—Tension—Timolol—glaucoma	0.000126	0.000614	CcSEcCtD
Bupivacaine—Pain—Clonidine—glaucoma	0.000126	0.000614	CcSEcCtD
Bupivacaine—Constipation—Clonidine—glaucoma	0.000126	0.000614	CcSEcCtD
Bupivacaine—Nervous system disorder—Betaxolol—glaucoma	0.000126	0.000613	CcSEcCtD
Bupivacaine—Tachycardia—Betaxolol—glaucoma	0.000126	0.00061	CcSEcCtD
Bupivacaine—Nervousness—Timolol—glaucoma	0.000125	0.000608	CcSEcCtD
Bupivacaine—Skin disorder—Betaxolol—glaucoma	0.000125	0.000607	CcSEcCtD
Bupivacaine—Vomiting—Dorzolamide—glaucoma	0.000125	0.000605	CcSEcCtD
Bupivacaine—Hyperhidrosis—Betaxolol—glaucoma	0.000124	0.000605	CcSEcCtD
Bupivacaine—Headache—Dorzolamide—glaucoma	0.000123	0.000596	CcSEcCtD
Bupivacaine—Vomiting—Brinzolamide—glaucoma	0.000123	0.000595	CcSEcCtD
Bupivacaine—Dizziness—Pilocarpine—glaucoma	0.000122	0.000595	CcSEcCtD
Bupivacaine—Headache—Travoprost—glaucoma	0.000122	0.000594	CcSEcCtD
Bupivacaine—Nausea—Brimonidine—glaucoma	0.000122	0.000592	CcSEcCtD
Bupivacaine—Feeling abnormal—Clonidine—glaucoma	0.000122	0.000592	CcSEcCtD
Bupivacaine—Vision blurred—Timolol—glaucoma	0.000121	0.00059	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Clonidine—glaucoma	0.000121	0.000587	CcSEcCtD
Bupivacaine—Headache—Brinzolamide—glaucoma	0.000121	0.000586	CcSEcCtD
Bupivacaine—Hypotension—Betaxolol—glaucoma	0.00012	0.000584	CcSEcCtD
Bupivacaine—Angioedema—Timolol—glaucoma	0.000118	0.000572	CcSEcCtD
Bupivacaine—Vomiting—Pilocarpine—glaucoma	0.000118	0.000572	CcSEcCtD
Bupivacaine—Urticaria—Clonidine—glaucoma	0.000118	0.000571	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000117	0.00057	CcSEcCtD
Bupivacaine—Abdominal pain—Clonidine—glaucoma	0.000117	0.000568	CcSEcCtD
Bupivacaine—Body temperature increased—Clonidine—glaucoma	0.000117	0.000568	CcSEcCtD
Bupivacaine—Insomnia—Betaxolol—glaucoma	0.000116	0.000566	CcSEcCtD
Bupivacaine—Nausea—Dorzolamide—glaucoma	0.000116	0.000565	CcSEcCtD
Bupivacaine—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000116	0.00252	CbGpPWpGaD
Bupivacaine—Headache—Pilocarpine—glaucoma	0.000116	0.000564	CcSEcCtD
Bupivacaine—Nausea—Travoprost—glaucoma	0.000116	0.000563	CcSEcCtD
Bupivacaine—Paraesthesia—Betaxolol—glaucoma	0.000116	0.000562	CcSEcCtD
Bupivacaine—Syncope—Timolol—glaucoma	0.000116	0.000561	CcSEcCtD
Bupivacaine—Dyspnoea—Betaxolol—glaucoma	0.000115	0.000558	CcSEcCtD
Bupivacaine—Nausea—Brinzolamide—glaucoma	0.000114	0.000556	CcSEcCtD
Bupivacaine—Palpitations—Timolol—glaucoma	0.000114	0.000553	CcSEcCtD
Bupivacaine—Dyspepsia—Betaxolol—glaucoma	0.000113	0.00055	CcSEcCtD
Bupivacaine—Loss of consciousness—Timolol—glaucoma	0.000113	0.00055	CcSEcCtD
Bupivacaine—Cough—Timolol—glaucoma	0.000112	0.000546	CcSEcCtD
Bupivacaine—Decreased appetite—Betaxolol—glaucoma	0.000112	0.000544	CcSEcCtD
Bupivacaine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000112	0.00242	CbGpPWpGaD
Bupivacaine—PTGER1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000111	0.00242	CbGpPWpGaD
Bupivacaine—Hypertension—Timolol—glaucoma	0.000111	0.00054	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Betaxolol—glaucoma	0.000111	0.00054	CcSEcCtD
Bupivacaine—Pain—Betaxolol—glaucoma	0.00011	0.000535	CcSEcCtD
Bupivacaine—Constipation—Betaxolol—glaucoma	0.00011	0.000535	CcSEcCtD
Bupivacaine—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.00011	0.00239	CbGpPWpGaD
Bupivacaine—Nausea—Pilocarpine—glaucoma	0.00011	0.000534	CcSEcCtD
Bupivacaine—Arthralgia—Timolol—glaucoma	0.00011	0.000533	CcSEcCtD
Bupivacaine—Anxiety—Timolol—glaucoma	0.000109	0.000531	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000109	0.000529	CcSEcCtD
Bupivacaine—Hypersensitivity—Clonidine—glaucoma	0.000109	0.000529	CcSEcCtD
Bupivacaine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000107	0.00232	CbGpPWpGaD
Bupivacaine—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000107	0.00231	CbGpPWpGaD
Bupivacaine—Asthenia—Clonidine—glaucoma	0.000106	0.000515	CcSEcCtD
Bupivacaine—Feeling abnormal—Betaxolol—glaucoma	0.000106	0.000515	CcSEcCtD
Bupivacaine—Confusional state—Timolol—glaucoma	0.000106	0.000515	CcSEcCtD
Bupivacaine—Anaphylactic shock—Timolol—glaucoma	0.000105	0.000511	CcSEcCtD
Bupivacaine—Oedema—Timolol—glaucoma	0.000105	0.000511	CcSEcCtD
Bupivacaine—Pruritus—Clonidine—glaucoma	0.000105	0.000508	CcSEcCtD
Bupivacaine—Infection—Timolol—glaucoma	0.000105	0.000508	CcSEcCtD
Bupivacaine—Shock—Timolol—glaucoma	0.000104	0.000503	CcSEcCtD
Bupivacaine—Nervous system disorder—Timolol—glaucoma	0.000103	0.000501	CcSEcCtD
Bupivacaine—CYP1A2—Phase II conjugation—GSTT1—glaucoma	0.000103	0.00224	CbGpPWpGaD
Bupivacaine—Urticaria—Betaxolol—glaucoma	0.000102	0.000497	CcSEcCtD
Bupivacaine—Skin disorder—Timolol—glaucoma	0.000102	0.000496	CcSEcCtD
Bupivacaine—Body temperature increased—Betaxolol—glaucoma	0.000102	0.000494	CcSEcCtD
Bupivacaine—Hyperhidrosis—Timolol—glaucoma	0.000102	0.000494	CcSEcCtD
Bupivacaine—Diarrhoea—Clonidine—glaucoma	0.000101	0.000491	CcSEcCtD
Bupivacaine—PTGER1—Signaling Pathways—OPN4—glaucoma	9.84e-05	0.00214	CbGpPWpGaD
Bupivacaine—Hypotension—Timolol—glaucoma	9.83e-05	0.000477	CcSEcCtD
Bupivacaine—Dizziness—Clonidine—glaucoma	9.78e-05	0.000475	CcSEcCtD
Bupivacaine—PTGER1—GPCR ligand binding—EDN1—glaucoma	9.72e-05	0.00211	CbGpPWpGaD
Bupivacaine—Musculoskeletal discomfort—Timolol—glaucoma	9.58e-05	0.000465	CcSEcCtD
Bupivacaine—Insomnia—Timolol—glaucoma	9.52e-05	0.000462	CcSEcCtD
Bupivacaine—Hypersensitivity—Betaxolol—glaucoma	9.49e-05	0.000461	CcSEcCtD
Bupivacaine—Paraesthesia—Timolol—glaucoma	9.45e-05	0.000459	CcSEcCtD
Bupivacaine—Vomiting—Clonidine—glaucoma	9.4e-05	0.000457	CcSEcCtD
Bupivacaine—Dyspnoea—Timolol—glaucoma	9.38e-05	0.000455	CcSEcCtD
Bupivacaine—Somnolence—Timolol—glaucoma	9.35e-05	0.000454	CcSEcCtD
Bupivacaine—Headache—Clonidine—glaucoma	9.27e-05	0.00045	CcSEcCtD
Bupivacaine—Dyspepsia—Timolol—glaucoma	9.26e-05	0.00045	CcSEcCtD
Bupivacaine—Asthenia—Betaxolol—glaucoma	9.24e-05	0.000449	CcSEcCtD
Bupivacaine—PTGER1—Signaling Pathways—HEYL—glaucoma	9.15e-05	0.00199	CbGpPWpGaD
Bupivacaine—Decreased appetite—Timolol—glaucoma	9.15e-05	0.000444	CcSEcCtD
Bupivacaine—Pruritus—Betaxolol—glaucoma	9.11e-05	0.000442	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Timolol—glaucoma	9.08e-05	0.000441	CcSEcCtD
Bupivacaine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	9.05e-05	0.00196	CbGpPWpGaD
Bupivacaine—Pain—Timolol—glaucoma	9e-05	0.000437	CcSEcCtD
Bupivacaine—PTGER1—Signaling Pathways—PTGFR—glaucoma	8.86e-05	0.00192	CbGpPWpGaD
Bupivacaine—Diarrhoea—Betaxolol—glaucoma	8.81e-05	0.000428	CcSEcCtD
Bupivacaine—Nausea—Clonidine—glaucoma	8.79e-05	0.000427	CcSEcCtD
Bupivacaine—Feeling abnormal—Timolol—glaucoma	8.67e-05	0.000421	CcSEcCtD
Bupivacaine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	8.61e-05	0.00187	CbGpPWpGaD
Bupivacaine—Gastrointestinal pain—Timolol—glaucoma	8.6e-05	0.000418	CcSEcCtD
Bupivacaine—Dizziness—Betaxolol—glaucoma	8.52e-05	0.000414	CcSEcCtD
Bupivacaine—SCN4A—Axon guidance—MMP2—glaucoma	8.52e-05	0.00185	CbGpPWpGaD
Bupivacaine—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	8.5e-05	0.00185	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR ligand binding—C3—glaucoma	8.49e-05	0.00184	CbGpPWpGaD
Bupivacaine—Urticaria—Timolol—glaucoma	8.36e-05	0.000406	CcSEcCtD
Bupivacaine—Body temperature increased—Timolol—glaucoma	8.32e-05	0.000404	CcSEcCtD
Bupivacaine—Abdominal pain—Timolol—glaucoma	8.32e-05	0.000404	CcSEcCtD
Bupivacaine—SCN10A—Axon guidance—MMP2—glaucoma	8.21e-05	0.00178	CbGpPWpGaD
Bupivacaine—Vomiting—Betaxolol—glaucoma	8.19e-05	0.000398	CcSEcCtD
Bupivacaine—Headache—Betaxolol—glaucoma	8.07e-05	0.000392	CcSEcCtD
Bupivacaine—Hypersensitivity—Timolol—glaucoma	7.75e-05	0.000376	CcSEcCtD
Bupivacaine—CYP2C19—Biological oxidations—GSTT1—glaucoma	7.74e-05	0.00168	CbGpPWpGaD
Bupivacaine—Nausea—Betaxolol—glaucoma	7.65e-05	0.000371	CcSEcCtD
Bupivacaine—PTGER1—Signaling by GPCR—SMO—glaucoma	7.56e-05	0.00164	CbGpPWpGaD
Bupivacaine—Asthenia—Timolol—glaucoma	7.55e-05	0.000367	CcSEcCtD
Bupivacaine—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	7.47e-05	0.00162	CbGpPWpGaD
Bupivacaine—Pruritus—Timolol—glaucoma	7.44e-05	0.000361	CcSEcCtD
Bupivacaine—Diarrhoea—Timolol—glaucoma	7.2e-05	0.00035	CcSEcCtD
Bupivacaine—CYP2D6—Biological oxidations—GSTT1—glaucoma	7.12e-05	0.00155	CbGpPWpGaD
Bupivacaine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	6.98e-05	0.00152	CbGpPWpGaD
Bupivacaine—Dizziness—Timolol—glaucoma	6.96e-05	0.000338	CcSEcCtD
Bupivacaine—PTGER1—Signaling Pathways—RPTOR—glaucoma	6.93e-05	0.00151	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NCK2—glaucoma	6.72e-05	0.00146	CbGpPWpGaD
Bupivacaine—Vomiting—Timolol—glaucoma	6.69e-05	0.000325	CcSEcCtD
Bupivacaine—Headache—Timolol—glaucoma	6.59e-05	0.00032	CcSEcCtD
Bupivacaine—CYP1A2—Phase II conjugation—GSTM1—glaucoma	6.57e-05	0.00143	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—MMP9—glaucoma	6.4e-05	0.00139	CbGpPWpGaD
Bupivacaine—Nausea—Timolol—glaucoma	6.25e-05	0.000303	CcSEcCtD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	6.22e-05	0.00135	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—MMP9—glaucoma	6.17e-05	0.00134	CbGpPWpGaD
Bupivacaine—CYP2C19—Biological oxidations—CYP1B1—glaucoma	6.17e-05	0.00134	CbGpPWpGaD
Bupivacaine—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	6.08e-05	0.00132	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—MMP2—glaucoma	6.08e-05	0.00132	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—GSTT1—glaucoma	6.03e-05	0.00131	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	5.89e-05	0.00128	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	5.89e-05	0.00128	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—MMP2—glaucoma	5.86e-05	0.00127	CbGpPWpGaD
Bupivacaine—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	5.82e-05	0.00126	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	5.76e-05	0.00125	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—VEGFA—glaucoma	5.75e-05	0.00125	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—HDAC9—glaucoma	5.71e-05	0.00124	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—CYP1B1—glaucoma	5.67e-05	0.00123	CbGpPWpGaD
Bupivacaine—CYP2D6—Metapathway biotransformation—CYP1B1—glaucoma	5.59e-05	0.00121	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—VEGFA—glaucoma	5.54e-05	0.0012	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—EDN1—glaucoma	5.49e-05	0.00119	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CA5A—glaucoma	5.42e-05	0.00118	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NARFL—glaucoma	5.42e-05	0.00118	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NARFL—glaucoma	4.99e-05	0.00108	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CA5A—glaucoma	4.99e-05	0.00108	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—EDN1—glaucoma	4.99e-05	0.00108	CbGpPWpGaD
Bupivacaine—CYP2C19—Biological oxidations—GSTM1—glaucoma	4.93e-05	0.00107	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	4.9e-05	0.00106	CbGpPWpGaD
Bupivacaine—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	4.86e-05	0.00106	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—CYP1B1—glaucoma	4.81e-05	0.00104	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—C3—glaucoma	4.8e-05	0.00104	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	4.74e-05	0.00103	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—GSTT1—glaucoma	4.65e-05	0.00101	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—MMP9—glaucoma	4.57e-05	0.000992	CbGpPWpGaD
Bupivacaine—CYP2D6—Biological oxidations—GSTM1—glaucoma	4.53e-05	0.000985	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.49e-05	0.000975	CbGpPWpGaD
Bupivacaine—CYP2D6—Metapathway biotransformation—GSTM1—glaucoma	4.47e-05	0.000971	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SMO—glaucoma	4.47e-05	0.00097	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—MMP9—glaucoma	4.4e-05	0.000956	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—C3—glaucoma	4.36e-05	0.000946	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CA5A—glaucoma	4.23e-05	0.000918	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NARFL—glaucoma	4.23e-05	0.000918	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	4.2e-05	0.000912	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	4.2e-05	0.000912	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—VEGFA—glaucoma	4.1e-05	0.00089	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NTRK2—glaucoma	4.09e-05	0.000887	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—VEGFA—glaucoma	3.95e-05	0.000859	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—GSTM1—glaucoma	3.84e-05	0.000834	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	3.79e-05	0.000823	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—CYP1B1—glaucoma	3.71e-05	0.000805	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	3.66e-05	0.000794	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—TNF—glaucoma	3.52e-05	0.000763	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NGFR—glaucoma	3.51e-05	0.000761	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—TNF—glaucoma	3.39e-05	0.000736	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NTRK1—glaucoma	3.33e-05	0.000723	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CA5A—glaucoma	3.26e-05	0.000708	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NARFL—glaucoma	3.26e-05	0.000708	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CDKN2B—glaucoma	3.07e-05	0.000667	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—GSTM1—glaucoma	2.96e-05	0.000644	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—EDN1—glaucoma	2.95e-05	0.00064	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	2.92e-05	0.000635	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NGF—glaucoma	2.71e-05	0.000588	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CA1—glaucoma	2.65e-05	0.000575	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—C3—glaucoma	2.57e-05	0.000559	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CTSA—glaucoma	2.57e-05	0.000557	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CA1—glaucoma	2.44e-05	0.000529	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CA2—glaucoma	2.42e-05	0.000526	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—APOE—glaucoma	2.4e-05	0.00052	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CAV1—glaucoma	2.37e-05	0.000515	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	2.37e-05	0.000514	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	2.37e-05	0.000514	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CTSA—glaucoma	2.36e-05	0.000512	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—FN1—glaucoma	2.26e-05	0.000491	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—BAD—glaucoma	2.23e-05	0.000485	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CA2—glaucoma	2.23e-05	0.000484	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CA1—glaucoma	2.06e-05	0.000448	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CTSA—glaucoma	2e-05	0.000434	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CA2—glaucoma	1.89e-05	0.00041	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.85e-05	0.000401	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.85e-05	0.000401	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—NOS3—glaucoma	1.79e-05	0.00039	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—TXN—glaucoma	1.71e-05	0.000371	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CA1—glaucoma	1.59e-05	0.000346	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—TXN—glaucoma	1.57e-05	0.000341	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.56e-05	0.000338	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CDKN1B—glaucoma	1.55e-05	0.000338	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.54e-05	0.000335	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CTSA—glaucoma	1.54e-05	0.000335	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CA2—glaucoma	1.46e-05	0.000316	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MMP9—glaucoma	1.44e-05	0.000313	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—TXN—glaucoma	1.33e-05	0.000289	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTT1—glaucoma	1.32e-05	0.000287	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—VEGFA—glaucoma	1.29e-05	0.000281	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTT1—glaucoma	1.22e-05	0.000264	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.21e-05	0.000264	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.2e-05	0.000261	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	1.07e-05	0.000232	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP1B1—glaucoma	1.05e-05	0.000229	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ABCA1—glaucoma	1.05e-05	0.000229	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTT1—glaucoma	1.03e-05	0.000224	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—TXN—glaucoma	1.03e-05	0.000223	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TP53—glaucoma	9.77e-06	0.000212	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ABCA1—glaucoma	9.7e-06	0.000211	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP1B1—glaucoma	9.7e-06	0.000211	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTM1—glaucoma	8.43e-06	0.000183	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.32e-06	0.000181	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP1B1—glaucoma	8.22e-06	0.000178	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ABCA1—glaucoma	8.22e-06	0.000178	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTT1—glaucoma	7.96e-06	0.000173	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTM1—glaucoma	7.75e-06	0.000168	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—MTHFR—glaucoma	7.45e-06	0.000162	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—APOE—glaucoma	6.94e-06	0.000151	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CAV1—glaucoma	6.87e-06	0.000149	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—MTHFR—glaucoma	6.85e-06	0.000149	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTM1—glaucoma	6.57e-06	0.000143	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—APOE—glaucoma	6.38e-06	0.000139	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ABCA1—glaucoma	6.34e-06	0.000138	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP1B1—glaucoma	6.34e-06	0.000138	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CAV1—glaucoma	6.32e-06	0.000137	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—MTHFR—glaucoma	5.81e-06	0.000126	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—APOE—glaucoma	5.41e-06	0.000117	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CAV1—glaucoma	5.36e-06	0.000116	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NOS3—glaucoma	5.2e-06	0.000113	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTM1—glaucoma	5.07e-06	0.00011	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NOS3—glaucoma	4.78e-06	0.000104	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PTGS2—glaucoma	4.75e-06	0.000103	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—MTHFR—glaucoma	4.48e-06	9.73e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PTGS2—glaucoma	4.37e-06	9.49e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—APOE—glaucoma	4.17e-06	9.06e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CAV1—glaucoma	4.13e-06	8.97e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NOS3—glaucoma	4.05e-06	8.79e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PTGS2—glaucoma	3.7e-06	8.04e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NOS3—glaucoma	3.13e-06	6.79e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PTGS2—glaucoma	2.86e-06	6.21e-05	CbGpPWpGaD
